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Abstract Myogenesis has been a leading model for elu-
cidating the molecular mechanisms that underlie tissue
differentiation and development since the discovery of
MyoD. During myogenesis, the fate of myogenic precursor
cells is ﬁrst determined by Pax3/Pax7. This is followed by
regulation of the myogenic differentiation program by
muscle regulatory factors (Myf5, MyoD, Myog, and Mrf4)
to form muscle tissues. Recent studies have uncovered a
detailed myogenic program that involves the RP58
(Zfp238)-dependent regulatory network, which is critical
for repressing the expression of inhibitor of DNA binding
(Id) proteins. These novel ﬁndings contribute to a com-
prehensive understanding of the muscle differentiation
transcriptional program.
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Introduction
Vertebrate skeletal muscle is derived from the somites,
which are established as paraxial mesoderm beside the
neural tube and notochord (Fig. 1a) [1]. The somite pro-
gressively subdivides into two compartments, the dorsal
dermomyotome and ventral sclerotome (Fig. 1b). The
dorsal dermomyotome further splits into the dermatome
and myotome in later stages of development to produce the
trunk dermis and muscles, respectively. Myogenic
precursor cells undergo an epithelial-mesenchymal transi-
tion (EMT) in response to signals from environmental cues,
delaminate from the dermomyotome, and accumulate
underneath to form the myotome (Fig. 1c) [2].
The dermomyotome can also be divided into dorsal
(epaxial) and ventral (hypaxial) portions, though no obvi-
ous morphological epaxial-hypaxial boundary exists. Sonic
hedgehog (SHH) secreted from the ﬂoor plate and noto-
chord speciﬁes the epaxial dermomyotome, and gives rise
to the epaxial myotome that forms the back muscles [3].
The hypaxial dermomyotome is speciﬁed by signals from
the dorsal ectoderm (Wnt pathway) and the lateral plate
mesoderm (Bmp4), and produces the hypaxial myotome
that forms the limbs, diaphragm, and body wall muscles
(Fig. 1b, c) [4].
All myogenic precursor cells in the dermomyotome
express the paired-homeodomain transcription factor, Pax3
[2]. When myogenesis begins, Pax3 expression gradually
decreases, and expression of basic helix-loop-helix (bHLH)
transcription factors known as muscle regulatory factors
(MRFs), such as Myf5, MyoD, Myog, and Mrf4, signiﬁ-
cantly increases [2]. These cells are then speciﬁed as
myoblasts, fuse with each other, and ﬁnally differentiate
into skeletal muscle ﬁbers.
Gene targeting analysis using mouse models over the
last 2 decades have shown that among these MRFs, Myf5
and MyoD are critical for myoblast determination and
exhibit redundant functions. Although inactivation of either
gene alone has no effect on skeletal muscle phenotype at
the embryonic stage, Myf5/MyoD double knockout (DKO)
mice have a complete lack of myoblasts and skeletal
muscle throughout the body [5]. In contrast, Myog is a
transcription factor that plays an essential role during
muscle differentiation. Indeed, while myoblasts are speci-
ﬁed normally in Myog KO mice, they cannot differentiate
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123into myotubes [6, 7]. Myog is considered a direct down-
stream target of Myf5 and MyoD in the muscle gene
network, and other MRFs cannot compensate for the defect
[6, 7]. Mrf4 was ﬁrst suggested to have a redundant func-
tion with Myog under the control of Myf5 and MyoD [8],
but recent studies have shown that Mrf4 functions as a
determinant of myogenic lineage in the early myotome
(primary myogenesis) [9].
The early myotome possesses a distinct lineage that
arises through the division of epaxial and hypaxial myo-
tome regions. The epaxial myotome is formed by
myoblasts derived from the dorsomedial lip of the
dermomyotome. These myoblasts ﬁrst express Myf5.O n
the other hand, the hypaxial myotome is formed by
myoblasts derived from the ventrolateral lip of the
dermomyotome. These myoblasts predominantly express
MyoD (Fig. 1b). Though both Myf5 and MyoD single
mutant mice show relatively normal muscle phenotypes,
other abnormalities have been observed. Myf5-/-
embryos show normal muscle development in the limb
buds, but markedly delayed development of epaxial
muscles. In contrast, while MyoD-/- mice display nor-
mal development of epaxial muscles, the development of
limb muscles are signiﬁcantly delayed. These results
indicate that, even in the early myotome, at least two
distinct myoblasts speciﬁed by the Myf5 and MyoD
pathways exist and play different roles in muscle devel-
opment [10].
Limb muscle development
While the hypaxial dermomyotome in the ﬂank (inter-limb)
elongates as epithelial sheets that give rise to body wall
muscles and intercostal muscles, the hypaxial dermomyo-
tome cells in the adjacent limb regions leave the epithelial
structure after EMT and begin migrating towards their
destination, i.e., the fore- and hind-limb bud mesenchyme
[11]. These long-range migratory myogenic precursor cells
express Pax3, retain their proliferative state, and do not
express MRFs during the migration (Fig. 2a). After they
reach the target destination, dorsal and ventral muscle-
forming regions in the limb bud begin to express MRFs,
downregulate Pax3, and ﬁnally differentiate into muscle
ﬁbers [2]. Splotch mutant mice, which lack functional
Pax3, are devoid of all limb muscles because of defects in
the migration of precursors from the somites to the limb
bud [12].
The key molecules involved in EMT of these myogenic
precursor cells are hepatocyte growth factor/scatter factor
(HGF/SF) and its receptor, c-Met [11]. These migratory
myogenic precursor cells in the hypaxial lip of the
dermomyotome express c-Met in addition to Pax3 [11, 12]
(Fig. 2B). In contrast, HGF/SF mRNA is predominantly
expressed in the adjacent limb mesenchyme [11, 13]. Both
c-Met-/- and HGF/SF-/- mice have muscle-free limbs,
resembling the Splotch phenotype, due to the lack of
myogenic precursor cell migration from the dermomyo-
tome to the limb [11, 14]. c-Met is considered a
downstream target of Pax3 because the Splotch mutant
shows a loss of c-Met expression in the hypaxial dermo-
myotome [12]. However, it is unclear whether c-Met is a
direct Pax3 target in vivo [15] and if these c-Met (?)
precursor cells have a chemotactic response to HGF/SF
[11, 13, 16].
Long-range migratory myogenic precursor cells are
generated only in the occipital, cervical, and fore- and
hindlimb levels of the dermomyotome ventrolateral lip.
These precursors speciﬁcally express the Lbx1 homeobox
transcription factor (Fig. 2b) [17]. Lbx1 inactivation leads
to the lack of dorsal muscle mass in the forelimb and all
Fig. 1 A schematic representation of somite patterning. a Each
somite (S) forms beside the neural tube (NT) and notochord (N),
adjacent to the lateral plate mesoderm (LPM). b The dorsal portion of
the somite differentiates into the dermomyotome (DM), while the
ventral quadrant gives rise to the sclerotome (SC). Signals from the
ﬂoor plate and notochord (SHH) then specify the epaxial portion of
the dermomyotome (yellow). Signals from the surface ectoderm
(E; Wnt7a) and lateral plate mesoderm (BMP4) specify the hypaxial
dermomyotome (green). c The two dermomyotome regions each
produce a compartment of the myotome (M). The epaxial myotome
forms from the epaxial lip of the dermomyotome (yellow), while the
hypaxial myotome forms from the hypaxial lip (green)
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123muscles in the hindlimb. In this mutant, c-Met (?)
migrating precursors are correctly speciﬁed and delaminate
from the ventrolateral lip of the dermomyotome, but cannot
enter laterally into the limb bud [11]. These results suggest
that Lbx1 is important for migratory myogenic precursor
cells to ﬁnd the correct guidance cues to the limb bud. It is
not known why precursors of the ventrolateral lip of the
inter-limb region, which express both Pax3 and c-Met, can
exclude Lbx1 expression.
Other genes expressed in migratory myogenic cells
Six family transcription factors (Six1, Six4) and Eya
transcriptional cofactors (Eya1, Eya2) are also critical for
hypaxial muscle speciﬁcation and the migration of hyp-
axial myogenic precursor cells from the somites to the
limb. In both Six1/Six4 and Eya1/Eya2 DKO mice, Pax3 is
absent from the hypaxial dermomyotome, resulting in
severe defects of precursor cell migration into the limb bud
Fig. 2 a Pax3 expression in the mouse embryo. Pax3 mRNA is not
detected in the hindlimb at E9.5. The dashed line outlines the
hindlimb bud. Arrows mark Pax3 (?) cells that have migrated into the
limbs of the E10.5 embryo. The right panel is an enlargement of
the central panel. Labeled structures are the dorsomedial lip of the
dermomyotome (DML), ventrolateral lip of the dermomyotome
(VLL), forelimb (FL), hindlimb (HL), neural tube (NT), heart (H),
and nasal pit (N). b Schematic representation of the expression
patterns of genes involved in dermomyotome development. Blue cells
indicate myogenic precursor cells migrating to the limb bud. c A
model of genes responsible for the development and migration of
myogenic precursor cells to the limb bud. The migrating myogenic
precursors delaminate from the VLL and populate in the dorsal
(dmm) and ventral muscle masses (vmm) in the limb bud. Six1/4,
Eya1/2, and Pax3 are indispensable for the speciﬁcation of myogenic
precursor cells in the ventrolateral lip of the dermomyotome. c-Met is
important for the delamination of VLL cells. Migrating myogenic
precursor cells express Pax3, c-Met, Lbx1, CXCR4, Sp5, and Pitx2.
Muscle differentiation within the limb is controlled by the expression
of the MRFs, Pitx3, and RP58
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123(Fig. 2c) [18, 19]. This indicates that Six and Eya proteins
function as upstream regulators of Pax3 during the estab-
lishment of the hypaxial dermomyotome.
Sp5 is expressed in the dorsomedial and ventrolateral
lips of the dermomyotome, overlapping with the expression
pattern of Pax3 [20]. Sp5 mRNA is also detected in
migrating myogenic precursor cells from the dermomyo-
tome to the limb, and its expression is not detected in
Splotch mice, suggesting that Sp5 is expressed in migratory
muscle precursors and its expression is regulated by Pax3
[20] (Fig. 2c).
Pitx2 and Pitx3 are also expressed in limb muscles
(Fig. 2c) [21]. Pitx2 is expressed in migratory myogenic
precursor cells, whereas Pitx3 can be seen during muscle
differentiation. Pitx3 mutant mice show upregulated and
prolonged Pitx2 expression, suggesting that Pitx2 and Pitx3
may be partially redundant [21].
Recent studies have shown that the chemokine receptor
CXCR4 is also expressed in migratory myogenic precursor
cells (Fig. 2c) [22]. The CXCR4 ligand, stromal derived
factor 1 (Sdf1), is speciﬁcally expressed in the middle
mesenchyme of the limb bud, which is the ﬁnal destination
of these migratory cells. Ectopic Sdf1 expression in the
chick limb bud causes an aberrant accumulation of CXCR4
(?) myogenic cells near the source. In CXCR4-/- mice,
fewer progenitor cells reach the limb bud and apoptosis
increases, suggesting an important role of CXCR4 for
migratory cues and cell survival [22]. CXCR4 genetically
interacts with Gab1, the adaptor molecule that mediates
interaction with the c-Met receptor. In CXCR4/Gab1 DKO
mice, the number of migratory myogenic cells reaching the
forelimb is signiﬁcantly reduced compared to each single
mutant, suggesting that a threshold number of precursor
cells reaching the limb is necessary to compensate for
muscle defects [22].
PAX transcription factors and the speciﬁcation
of myogenic precursor cells in gastrulation and adults
Myogenic precursor cells in the dermomyotome also
express Pax7, the analog of Pax3 [2]. Pax3 positive pre-
cursor cells accumulate in the dorsomedial and
ventrolateral lips of the dermomyotome during develop-
ment (Fig. 2a, b), while Pax7 expression is more prominent
in the central region of the dermomyotome [23, 24].
In the adult body, muscle growth and regeneration
events depend on the proliferation and differentiation of
muscle stem cells, termed satellite cells, which are located
under the basal lamina of muscle ﬁbers. These satellite
cells express Pax7 and are mitotically quiescent in
undamaged muscle. Upon injury, they are activated,
migrate to the injured area, proliferate, and fuse with each
other to replace degenerated muscle ﬁbers. This is
accompanied by upregulation of MRFs and the downreg-
ulation of Pax7. In Pax7-/- mice, satellite cells
progressively die by apoptosis after birth, and Pax3 cannot
compensate [25]. Recent ﬁndings suggest that Pax3 is also
expressed in many, but not all, satellite cells [25, 26].
Quiescent satellite cells also express the receptor c-Met,
and the ligand HGF/SF is a trigger for satellite cell acti-
vation [27]. These combined results indicate that Pax
transcription factors are important for the speciﬁcation and
maintenance of muscle progenitor cells both in early
somites and in adult muscle tissues, and suggest that a very
similar transcriptional network is orchestrated during
embryonic skeletal muscle formation and adult muscle
regeneration.
A population of skeletal muscle progenitor cells resides
in the central dermomyotome that expresses both Pax3 and
Pax7 [28, 29]. These Pax3(?)Pax7(?) cells are mitotically
active, do not co-express MRFs after entering the myo-
tome, and persist in all fetal and neonatal muscles [23, 24,
26]. Pax3/Pax7 DKO mice show some early embryonic
muscles of the myotome, but completely lack further
muscle development because of loss of the muscle pro-
genitor cell population [26]. Cells failing to express Pax3
or Pax7 either die or assume a non-myogenic fate. These
results indicate that Pax3(?)Pax7(?) mitotic progenitor
cells are responsible for fetal muscle growth (secondary
myogenesis) and contribute to satellite cells of postnatal
mice, suggesting that embryonic muscle progenitors and
satellite cells are commonly derived from the central
dermomyotome [24, 26].
MyoD and muscle differentiation
Weintraub’s discovery of MyoD in 1986 shed new light on
the molecular nature of skeletal muscle differentiation [30].
Weintraub’s group cloned MyoD by subtractive hybrid-
ization from azacytidine-treated myoblasts (by subtracting
cDNA of azacytidine-induced myoblasts from mouse
10T1/2 ﬁbroblasts) and demonstrated that MyoD alone was
enough to convert 10T1/2 ﬁbroblasts into myoblasts [31].
MyoD (as wells as other bHLH MRF factors) binds the
E-box sequence (CANNTG) in promoters of downstream
muscle target genes, thereby driving the transcription of
these muscle-related genes in collaboration with myocyte
enhancer factor 2 (Mef2) transcription factors (Fig. 3a)
[32]. Mef2C is speciﬁcally expressed in muscle tissues and
binds to DNA near E-boxes. Normally, these bHLH MRFs
dimerize with E-proteins (E12, E47 and HEB), which are
ubiquitous throughout the body, to activate downstream
gene expression [32]. However, in the presence of inhibitor
of DNA binding (Id) proteins (Id1–Id4), which are negative
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123regulators of myogenesis, MyoD cannot activate the tran-
scription of downstream target genes [33]. Ids can
heterodimerize with E-proteins (and to a lesser extent with
MyoD), thereby attenuating MyoD function (Fig. 3a).
Although the molecular mechanisms regulating the inhi-
bition of Id protein expression are unknown, we recently
found that the transcriptional repressor RP58 (mouse
Zfp238) is expressed in early differentiated muscle tissue
and represses Id2/Id3 expression, allowing MyoD to pro-
mote muscle differentiation (Fig. 3b) [34]. RP58 is ﬁrst
expressed in limb muscle tissues around E11.5, coincident
with Myog, and like Myog, is upregulated by acetylated
MyoD during early differentiation stages [34, 35]. These
results indicate that MyoD both activates (via Myog) and
represses (via RP58) a distinct gene set that permits the
progression of skeletal myogenesis to late differentiation
(Fig. 3c) [34, 36].
Future directions
Expression of the aristaless-like homeobox transcription
factor Alx4 demarcates the central region of the dermo-
myotome, excluding the dorsomedial and ventrolateral lips
[37]. En1 expression partially overlaps with Alx4 expres-
sion in the epaxial portion of the central dermomyotome
and is adjacent to expression of the bHLH transcription
factor Sim1, which is expressed in the hypaxial portion of
the central dermomyotome that overlaps with Alx4 [37].
Using fate mapping analysis in the mouse embryo, Atit
et al. [38] demonstrated that En1-expressing central
dermomyotomal cells have three distinct fates: dorsal
dermis, epaxial muscle, and, unexpectedly, some inter-
scapular brown fat. In addition, Ben-Yair et al. [39] showed
that a single cell in the central dermomyotome has the
potential to produce both myotome and dermatome cells by
asymmetric cell division. It is noted that En1 and Sim1 are
expressed not only in the dermomyotome, but also in the
adjacent myotome and dermis (Fig. 4). These results imply
that multipotent common progenitor cells that reside in the
central dermomyotome region can also express Sim1.
Moreover, these central dermomyotome cells are also Pax3
and Pax7 positive in early development (Fig. 2b, 4). It was
previously shown that Pax3 and Pax7 positive cells derived
from the central dermomyotome are also found in adult
muscle satellite cells beside the myotome, indicating that
muscle satellite cells have a common origin with embry-
onic myogenic precursor cells in the dermomyotome of
somites [24, 26]. Therefore, En1 may contribute to the
speciﬁcation of adult muscle satellite cells, although its
expression in these cells has not been reported.
Recent studies have shown that brown fat cells are
derived from skeletal muscle lineage progenitor cells. It
was previously thought that white fat cells and brown fat
cells have a common adipogenic origin. However, through
in vivo cell tracing analysis, Seale et al. showed that brown
fat cells are derived from Myf5 (a skeletal muscle-speciﬁc
transcription factor) positive muscle cells during early
development [40]. They also showed that the SET domain-
containing Zinc ﬁnger transcription factor Prdm16 deter-
mines the fate of these multipotent Myf5 positive
precursors to become brown fat cells. This ability of
Prdm16 is bidirectional. Prdm16 knockdown in brown fat
cells results in skeletal muscle-speciﬁc gene upregulation,
and its overexpression in C2 muscle cells causes down-
regulation of muscle genes and brown fat formation.
Fig. 3 MyoD activates target gene expression. a MyoD dimerizes
with E2A and binds to the E-box in promoters of muscle-speciﬁc
genes. Id proteins prevent the formation of MyoD/E2A heterodimers
and their DNA-binding activities. b RP58 represses Id2 and Id3
transcription by binding to the putative RP58 binding site in the Id2
and Id3 promoters. c Proposed myogenesis regulatory network via
RP58
Fig. 4 En1 and Sim1 are broadly expressed in the epaxial and
hypaxial compartments in the somites, respectively. Pax7 (?) and
Pax3 (?) cells predominantly reside in the central portion of the
dermomyotome, overlapping with Alx4 expression, and retain this
expression even after migrating to the myotome (M). DML dorso-
medial lip, VLL ventrolateral lip of the dermomyotome
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123Furthermore, Tseng et al. [41] found that Bmp7 can stim-
ulate the brown adipose lineage, activating Prdm16, Pgc-
1a, and the brown fat marker, uncoupling protein 1 (Ucp1).
Bmp7-/- mice show a dramatic reduction in brown fat
and an almost complete lack of Ucp1. In contrast,
Myog-/- mutant mice show ectopic brown adipocytes in
some regions that are normally skeletal muscle tissue [6].
This myoblast/brown adipocyte precursor may exhibit
some plasticity for cell fate and can switch fates based on
surrounding cues. This is very intriguing given the ability
of brown adipose tissue to burn fat. However, it is currently
unknown whether there are interactions between Prdm16
and Bmp7 expressing regions within the somites and cen-
tral dermomyotome where brown adipocytes are produced.
Further studies of the genetic interactions between
Prdm16/Bmp7 and genes expressed in the central dermo-
myotome, such as Alx4, En1, Sim1, Pax transcription
factors, and other unknown factors, will shed light on
mechanisms underlying the speciﬁcation of different cell
fates of central dermomyotome cells.
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